Ironwood Pharmaceuticals Shares Surge on Competitor's Woes
Wells Fargo Maintains Ironwood Pharmaceuticals(IRWD.US) With Buy Rating, Maintains Target Price $12
Here's Why Brown Capital Management Small Company Fund Sold Ironwood Pharmaceuticals (IRWD)
Jefferies Maintains Ironwood Pharmaceuticals(IRWD.US) With Buy Rating, Cuts Target Price to $12
Ironwood Pharmaceuticals On Pace for Largest Percent Increase Since January 2014 -- Data Talk
Beam Therapeutics Picks Ironwood Pharmaceuticals Finance and Operations Chief as CFO
Jimmy1819 : have you been investing professionally or as a hobby?
Coach Donnie : Awesome @Meltyy